Biolinq is pioneering a revolutionary biowearable platform focused on metabolic health. They have engineered a new category of ultra-small electrochemical sensors that continuously monitor multiple analytes just below the skin surface, offering a profound new biowearable experience.

With over $120 million invested and more than 500,000 hours of clinical data, Biolinq integrates cutting-edge biosensor design, consumer electronics, software-derived insights, and proprietary materials science. Their multi-sensor array delivers real-time, reliable data while prioritizing comfort and performance, enabling personalized medicine and new insights into metabolic health.

Biolinq aims to transform health monitoring through precision manufacturing and breakthrough innovation, delivering a new standard in biowearable technology that empowers individuals with meaningful health insights from their skin.